Cited by 18Pelvic floor disorders treatmentsHernia repair and managementUterine Myomas and Treatments

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

PROSPECT: 4- and 6-year follow-up of a randomised trial of surgery for vaginal prolapse

Open access

Abstract

Introduction and hypothesis: Our aim was to compare the mid-term results of native tissue, biological xenograft and polypropylene mesh surgery for women with vaginal wall prolapse. Methods: A total of 1348 women undergoing primary transvaginal repair of an anterior and/or posterior prolapse were recruited between January 2010 and August 2013 from 35 UK centres. They were randomised by remote allocation to native tissue surgery, biological xenograft or polypropylene mesh. We performed both 4- and 6-year follow-up using validated patient-reported outcome measures. Results: At 4 and 6 years post-operation, there was no clinically important difference in Pelvic Organ Prolapse Symptom Score for any of the treatments. Using a strict composite outcome to assess functional cure at 6 years, we found no difference in cure among the three types of surgery. Half the women were cured at 6 years but only 10.3 to 12% of women had undergone further surgery for prolapse. However, 8.4% of women in the mesh group had undergone further surgery for mesh complications. There was no difference in the incidence of chronic pain or dyspareunia between groups. Conclusions: At the mid-term outcome of 6 years, there is no benefit from augmenting primary prolapse repairs with polypropylene mesh inlays or biological xenografts. There was no evidence that polypropylene mesh inlays caused greater pain or dyspareunia than native tissue repairs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00192-022-05308-0

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. First Do No Harm. The report of the Independent Medicines and Medical Devices safety Review. 2020; Available at: https://www.immdsreview.org.uk/downloads/IMMDSReview_Web.pdf. Accessed 5 August, 2020.

Cited by

Sorted by citations

Metadata

Authors
Reid, F. M., Aucott, L., Glazener, C. M. A., Elders, A., Hemming, C., Cooper, K. G., Freeman, R. M., Smith, A. R. B., Hagen, S., Kilonzo, M., Boyers, D., MacLennan, G., Norrie, J., Breeman, S., & for the PROSPECT study group
Affiliations
  • Manchester Academic Health Science Centre (GB)
  • University of Aberdeen (GB)
  • Glasgow Caledonian University (GB)
  • Aberdeen Royal Infirmary (GB)
  • Plymouth Hospital (GB)
  • University of Edinburgh (GB)
Corresponding author
Reid, Fiona M.
Venue
International Urogynecology Journal
Published
2022-08-26
Volume
34
Issue
1
Pages
67-78
ISSN
  • 0937-3462 (ISSN-L)
  • 1433-3023
OpenAlex
W4293124689
Cited by
18
References
20
Citations by year
2026: 4 · 2025: 4 · 2024: 7 · 2023: 3
FWCI
2.55
Type
journal article
Language
en
Open access
Locations
  • International Urogynecology Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ResearchOnline (acceptedVersion, cc-by)
  • ResearchOnline (Glasgow Caledonian University) (submittedVersion, cc-by)
  • Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion, other-oa)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
  • Scottish Government
  • National Institute for Health and Care Research (07/60/18)
  • Department of Health and Social Care
  • Chief Scientist Office, Scottish Government Health and Social Care Directorate
Topics
  • Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
  • Health Sciences › Medicine › Surgery › Hernia repair and management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
Keywords
vaginal wall prolapse, transvaginal repair, native tissue repair, polypropylene mesh, pelvic organ prolapse, functional cure, mesh complications, chronic pain, dyspareunia, patient-reported outcomes, mid-term outcomes
MeSH terms
Dyspareunia, Female, Follow-Up Studies, Humans, Polypropylenes, Gynecologic Surgical Procedures, Surgical Mesh, Uterine Prolapse, Treatment Outcome, Pelvic Organ Prolapse

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review